Martin Forster, M.D., Ph.D., is an associate professor at University College London (UCL) and consultant medical oncologist at University College Hospital. He specialises in lung cancer, thoracic and head and neck cancers and has a particular interest in drug development and in using the increasing understanding of cancer biology to design studies that distinguish patient populations most likely to gain benefit from new drugs and new drug combinations. Professor Forster is a core member of the lung and head and neck cancer teams and runs a research-based practice, being principal investigator or chief investigator for over 50 early and late-phase clinical trials, from first-in-human to registration Phase III trials. Professor Forster is the current clinical lead for the UCL Experimental Cancer Medicine Centre (ECMC) and clinical lead for cancer research at the University College London Hospitals (UCLH).